Olympus boosts its approach to climate action

MedTech News: More companies are acknowledging that climate health affects human health in new ways – by changing infectious disease patterns and increasing the risk of drought and food insecurity. 

Olympus announced that from April 2022, the company has begun to exclusively source 100% of the electricity used at its major R&D and manufacturing sites from renewable sources.

As a result, CO2 emissions from Olympus Group facilities in Japan will be reduced by approximately 40,000 tons per year. The percentage of the Olympus Group’s total electricity use* in fiscal 2023 (ending March 2023) from renewable energy sources is expected to substantially increase from approximately 14% in the previous fiscal year to approximately 70%.

Olympus has set a goal of achieving net zero CO2 emissions from its site operations by 2030, as part of its commitment to achieving environmentally responsible business growth and creating a sustainable society. This is a key goal in line with our ESG materiality targets focused on the theme of a “carbon neutral society and circular economy.”

Top trends shifting the future of the medtech sector – Cardinal Health global leader

The company has already introduced a wide range of initiatives to reduce CO2 emissions. This includes the use of 100% renewable energy at some manufacturing sites in Europe and the United States, the installation of solar power generation facilities at some manufacturing sites in Japan, and support of the recommendations made by the Task Force on Climate-related Financial Disclosures (TCFD).

To achieve its carbon neutral goal, Olympus will continue to optimise manufacturing processes and promote energy-saving measures, is committed to further accelerate the shift to renewable energy sources across the company, thereby contributing to the decarbonization of society on a global level.

*Excluding recently acquired companies, certain service offices, and certain sales offices.